Swetchem Antibiotics Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
as on 30-12-2024
- Paid Up Capital ₹ 6.60 Cr
as on 30-12-2024
- Company Age 32 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 6.82 Cr
as on 30-12-2024
- Revenue %
(FY 2017)
- Profit -87.12%
(FY 2017)
- Ebitda -87.12%
(FY 2017)
- Net Worth -0.44%
(FY 2017)
- Total Assets -0.10%
(FY 2017)
About Swetchem Antibiotics
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 6.60 Cr.
The company has closed loans amounting to ₹6.82 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sukhdev Singh, Anil Shrivastava, and Razi Kidwai serve as directors at the Company.
- CIN/LLPIN
U24100DL1992PLC051252
- Company No.
051252
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
07 Dec 1992
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Swetchem Antibiotics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sukhdev Singh  | Director | 07-Dec-1992 | Current |
| Anil Shrivastava | Director | 07-Dec-1992 | Current |
| Razi Kidwai | Director | 30-Nov-2019 | Current |
Financial Performance of Swetchem Antibiotics.
Swetchem Antibiotics Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 87.12% decrease in profit. The company's net worth dipped by a decrease of 0.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Swetchem Antibiotics?
In 2017, Swetchem Antibiotics had a promoter holding of 50.91% and a public holding of 49.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Deodar And Pine Estate Developers Private LimitedActive 6 months 22 daysSukhdev Singh is a mutual person
- Trinityenviro Technology International Private LimitedActive 3 years 3 months
Sukhdev Singh is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Allahabad Industrial Finance Branch Creation Date: 14 May 1996 | ₹2.60 Cr | Satisfied |
Industrial Development Bank Of India Creation Date: 15 Jul 1994 | ₹4.22 Cr | Satisfied |
How Many Employees Work at Swetchem Antibiotics?
Unlock and access historical data on people associated with Swetchem Antibiotics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Swetchem Antibiotics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swetchem Antibiotics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
